Rapport Therapeutics Insider Bought Shares Worth $974,278, According to a Recent SEC Filing
MT newswire2026/10/22 21:03Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
05:03 PM EDT, 10/22/2026 (MT Newswires) -- Steven M Paul, Director, on October 22, 2026, executed a purchase for 35,714 shares in Rapport Therapeutics (RAPP) for $974,278. Following the Form 4 filing with the SEC, Paul has control over a total of 555,022 common shares of the company, with 477,642 shares held directly and 77,380 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2012593/000119312526429073/xslF345X05/ownership.xml
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
KWAP Sells 1,449,400 Top Glove Shares
Bitget•2026/10/29 09:39
US Dollar: Fed hawkish hold fails to extend gains – DBS
FXStreet•2026/10/29 09:30
